Authors:
Lara, PN
Higdon, R
Lim, N
Kwan, K
Tanaka, M
Lau, DHM
Wun, T
Welborn, J
Meyers, FJ
Christensen, S
O'Donnell, R
Richman, C
Scudder, SA
Tuscano, J
Gandara, DR
Lam, KS
Citation: Pn. Lara et al., Prospective evaluation of cancer clinical trial accrual patterns: Identifying potential barriers to enrollment, J CL ONCOL, 19(6), 2001, pp. 1728-1733
Authors:
Gandara, DR
Lara, PN
Goldberg, Z
Lau, DHM
Citation: Dr. Gandara et al., Integration of new chemotherapeutic agents into chemoradiotherapy for stage III non-small cell lung cancer: Focus on docetaxel, SEMIN ONCOL, 28(3), 2001, pp. 26-32
Authors:
Edelman, MJ
Gandara, DR
Lau, DHM
Lara, P
Lauder, IJ
Tracy, D
Citation: Mj. Edelman et al., Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma - Carboplatin and gemcitabine followed by paclitaxel, CANCER, 92(1), 2001, pp. 146-152
Citation: Dhm. Lau, Inhibition of NF-kappa B sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis - Invited commentary, ANN THORAC, 70(3), 2000, pp. 937-937